Search research articles
Contact Us
Filters
Showing results (11-20 of 26) with videos related to
Page
of 3
Sort By:
Undersea & Hyperbaric Medicine : Journal of the Undersea and Hyperbaric Medical Society, Inc
|
July 22, 1998
Histologic morphometry confirms a prophylactic effect for hyperbaric oxygen in the prevention of delayed radiation enteropathy
J J Feldmeier, D A Davolt, W S Court, et al.
Cancer Letters
|
February 1, 1986
Cisplatin and nifedipine: synergistic cytotoxicity against murine solid tumors and their metastases
J M Onoda, J R Jacobs, J D Taylor, et al.
Biochemical and Biophysical Research Communications
|
May 29, 1987
The role of platelet cyclooxygenase and lipoxygenase pathways in tumor cell induced platelet aggregation
K V Honn, B W Steinert, K Moin, et al.
Journal of the National Cancer Institute
|
May 1, 1987
Inhibition by prostacyclin of the tumor cell-induced platelet release reaction and platelet aggregation
D G Menter, J M Onoda, D Moilanen, et al.
Radiation Research
|
December 1, 1994
Inhibition of radiation-enhanced expression of integrin and metastatic potential in B16 melanoma cells by a lipoxygenase inhibitor
J M Onoda, S S Kantak, M P Piechocki, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
|
February 1, 1988
Separation of high and low metastatic subpopulations from solid tumors by centrifugal elutriation
J M Onoda, K K Nelson, I M Grossi, et al.
Clinical & Experimental Metastasis
|
January 1, 1984
Inhibition of tumor cell-platelet interactions and tumor metastasis by the calcium channel blocker, nimodipine
K V Honn, J M Onoda, C A Diglio, et al.
Clinical & Experimental Metastasis
|
January 1, 1990
Combination chemotherapy with cisplatin and nifedipine: synergistic antitumor effects against a cisplatin-resistant subline of the B16 amelanotic melanoma
J M Onoda, K K Nelson, S M Pilarski, et al.
Shock (Augusta, Ga.)
|
January 1, 1999
Aminothiol WR-1065 protects endothelial cell morphology against alterations induced by lipopolysaccharide
J L Podolski, S N Mooteri, E A Drab-Weiss, et al.
Radiation Research
|
February 1, 1996
WR-1065 and radioprotection of vascular endothelial cells. II. Morphology
S N Mooteri, J L Podolski, E A Drab, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 26) with videos related to
Sort By:
Page
of 3
Undersea & Hyperbaric Medicine : Journal of the Undersea and Hyperbaric Medical Society, Inc
|
July 22, 1998
Histologic morphometry confirms a prophylactic effect for hyperbaric oxygen in the prevention of delayed radiation enteropathy
J J Feldmeier, D A Davolt, W S Court, et al.
Cancer Letters
|
February 1, 1986
Cisplatin and nifedipine: synergistic cytotoxicity against murine solid tumors and their metastases
J M Onoda, J R Jacobs, J D Taylor, et al.
Biochemical and Biophysical Research Communications
|
May 29, 1987
The role of platelet cyclooxygenase and lipoxygenase pathways in tumor cell induced platelet aggregation
K V Honn, B W Steinert, K Moin, et al.
Journal of the National Cancer Institute
|
May 1, 1987
Inhibition by prostacyclin of the tumor cell-induced platelet release reaction and platelet aggregation
D G Menter, J M Onoda, D Moilanen, et al.
Radiation Research
|
December 1, 1994
Inhibition of radiation-enhanced expression of integrin and metastatic potential in B16 melanoma cells by a lipoxygenase inhibitor
J M Onoda, S S Kantak, M P Piechocki, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
|
February 1, 1988
Separation of high and low metastatic subpopulations from solid tumors by centrifugal elutriation
J M Onoda, K K Nelson, I M Grossi, et al.
Clinical & Experimental Metastasis
|
January 1, 1984
Inhibition of tumor cell-platelet interactions and tumor metastasis by the calcium channel blocker, nimodipine
K V Honn, J M Onoda, C A Diglio, et al.
Clinical & Experimental Metastasis
|
January 1, 1990
Combination chemotherapy with cisplatin and nifedipine: synergistic antitumor effects against a cisplatin-resistant subline of the B16 amelanotic melanoma
J M Onoda, K K Nelson, S M Pilarski, et al.
Shock (Augusta, Ga.)
|
January 1, 1999
Aminothiol WR-1065 protects endothelial cell morphology against alterations induced by lipopolysaccharide
J L Podolski, S N Mooteri, E A Drab-Weiss, et al.
Radiation Research
|
February 1, 1996
WR-1065 and radioprotection of vascular endothelial cells. II. Morphology
S N Mooteri, J L Podolski, E A Drab, et al.
Page
of 3